2015/07/04:  The pilot study of ETUARY® for the treatment of radiation-induced pneumonitis was initiated in Hefei, Anhui, and Vice President Dr. Lvhua Wang from the Cancer Hospital of the Chinese Academy of Medical Sciences, is the principal investigator for the study. More than a dozen of nationwide radiation oncology hospitals will participate in the trial.

2015/06/12  Japanese Journal Magazine of Pharmaceutical interviewed Dr. Luo to introduce the development prospects of new drugs in China.

2015/06/10  F351 Phase II clinical trials for the treatment of liver fibrosis were initiated in Shanghai, and Professor Lu Lungen from Shanghai First People’s Hospital, as well as Professor Cheng Jun from Beijing Ditan Hospital, are the principal investigators for the study. Thirteen Class AAA hospitals nationwide will participate in the trial.

2015/01/22  Company moved into the new R&D building purchased by itself and located at the Leader Park, Chuanhong Road, Pudong new Area. Domestic and foreign guests attended the opening ribbon-cutting ceremony for the building. The building is next to the Disney park. We enjoyed the beautiful environment in the park and more convenient transportation to the airport.

© 2007~2018 shanghaigenomics.com. All rights reserved. Shanghai ICP 08017875